EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epidemiological Studies on Type 2 Diabetes Using the German Disease Analyser Database: A Narrative Review

Karel Kostev iD, Henning Sievert, Marcel Konrad iD, Theresia Sarabhai

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Karel Kostev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Marburg University, University Clinic, Marburg, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The German IQVIA Disease Analyser (DA) database provides longitudinal, anonymised outpatient data from a large network of German general practices and specialist offices, including ICD‐10 diagnoses, ATC‐coded prescriptions, consultation dates and selected clinical measurements (HbA1c, BMI).

Aims

This narrative review synthesises DA‐based research in patients with type 2 diabetes (T2D) published between 2020 and 2025, with a focus on studies examining glucose‐lowering drug effectiveness, real‐world prescribing patterns, pharmacoepidemiological associations and relevant comorbidities.

Methods

A structured PubMed search was used to identify eligible studies, and methodological limitations of the included observational studies are discussed.

Results

Key findings include observational associations between SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia and dementia in patients with T2D, a decline in cardiovascular event incidence among patients with newly diagnosed T2D over a 17‐years period, a gap between guideline recommendations and real‐world use of GLP‐1 receptor agonists and SGLT2 inhibitors in patients with established cardiovascular disease, and associations between glucose‐lowering drug classes and cerebrovascular outcomes.

Discussion

Given the observational design of all included studies, these associations should be regarded as hypothesis‐generating rather than causal. The DA database complements randomised trial evidence by capturing large, heterogeneous populations in routine care. Limitations include underestimation of hypoglycaemia, absence of lifestyle and socioeconomic variables, and incomplete inpatient data, as well as reliance on a single data source to which several included studies and authors of this review have contributed.

Conclusion

DA‐based pharmacoepidemiological evidence is a valuable, albeit methodologically constrained, addition to the evidence base for contemporary diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsHumansGermanyDatabases, FactualSodium-Glucose Transporter 2 InhibitorsEpidemiologic StudiesGlucagon-Like Peptide-1 Receptor AgonistsObservational Studies as TopicPharmacoepidemiology

Stichwörter der Autor:innen

GLP‐1 receptor agonistsGermanySGLT2 inhibitorsdisease analyserpharmacoepidemiologyreal‐world evidencetype 2 diabetes

Substanzen

Hypoglycemic AgentsSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Marburg University, University Clinic, Marburg, Germany.
  • Epidemiology, IQVIA, Frankfurt, Germany.
  • Health & Social, FOM University of Applied Sciences for Economics and Management, Frankfurt am Main, Germany.
  • Department of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

ORCID-Profile: Karel Kostev, Marcel Konrad

Zitieren

APA

Kostev, K., Sievert, H., Konrad, M., & Sarabhai, T. (2026). Epidemiological Studies on Type 2 Diabetes Using the German Disease Analyser Database: A Narrative Review. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71089

Vancouver

Kostev K, Sievert H, Konrad M, Sarabhai T. Epidemiological Studies on Type 2 Diabetes Using the German Disease Analyser Database: A Narrative Review. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71089

BibTeX
@article{Kostev2026,
  author = {Kostev, Karel and Sievert, Henning and Konrad, Marcel and Sarabhai, Theresia},
  title = {Epidemiological Studies on Type 2 Diabetes Using the German Disease Analyser Database: A Narrative Review},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71089}
}
Kostenlos starten →